TY - JOUR
T1 - The Esophacoil stent for malignant esophageal obstruction
AU - Mayoral, W.
AU - Fleischer, D. E.
N1 - Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 1999
Y1 - 1999
N2 - Esophageal cancer is the seventh most common cause of cancerrelated deaths in men in the United States. For a disease in which 60% of patients are incurable at presentation, palliative therapy is the main treatment option. Palliative measures include surgery, radiation therapy, chemotherapy, photodynamic therapy, endoscopic dilation, endoscopic ablation, and the use of endoscopic prostheses. This article reviews the characteristics, technique, efficacy, and complications of the Esophacoil stent for malignant esophageal strictures.
AB - Esophageal cancer is the seventh most common cause of cancerrelated deaths in men in the United States. For a disease in which 60% of patients are incurable at presentation, palliative therapy is the main treatment option. Palliative measures include surgery, radiation therapy, chemotherapy, photodynamic therapy, endoscopic dilation, endoscopic ablation, and the use of endoscopic prostheses. This article reviews the characteristics, technique, efficacy, and complications of the Esophacoil stent for malignant esophageal strictures.
UR - http://www.scopus.com/inward/record.url?scp=0032793217&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032793217&partnerID=8YFLogxK
U2 - 10.1016/s1052-5157(18)30185-5
DO - 10.1016/s1052-5157(18)30185-5
M3 - Review article
C2 - 10388857
AN - SCOPUS:0032793217
SN - 1052-5157
VL - 9
SP - 423
EP - 430
JO - Gastrointestinal Endoscopy Clinics of North America
JF - Gastrointestinal Endoscopy Clinics of North America
IS - 3
ER -